Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Cash & Equivalents (2016 - 2025)

Solesence (SLSN) has disclosed Cash & Equivalents for 16 consecutive years, with $429000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents fell 85.33% year-over-year to $429000.0, compared with a TTM value of $429000.0 through Sep 2025, down 85.33%, and an annual FY2024 reading of $1.4 million, down 18.18% over the prior year.
  • Cash & Equivalents was $429000.0 for Q3 2025 at Solesence, down from $4.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $4.1 million in Q2 2025 and bottomed at $429000.0 in Q3 2025.
  • Average Cash & Equivalents over 5 years is $1.6 million, with a median of $1.4 million recorded in 2024.
  • The sharpest move saw Cash & Equivalents skyrocketed 232.72% in 2022, then tumbled 85.33% in 2025.
  • Year by year, Cash & Equivalents stood at $657000.0 in 2021, then surged by 232.72% to $2.2 million in 2022, then dropped by 21.23% to $1.7 million in 2023, then fell by 18.18% to $1.4 million in 2024, then plummeted by 69.55% to $429000.0 in 2025.
  • Business Quant data shows Cash & Equivalents for SLSN at $429000.0 in Q3 2025, $4.1 million in Q2 2025, and $1.8 million in Q1 2025.